Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 5. Activity on acute experimental synovitis in dogs.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004285:Dogs; D005260:Female; D007270:Injections, Intra-Articular; D008297:Male; D010653:Phenylbutazone / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use*; D012964:Sodium; D013585:Synovitis / Q000139:chemically induced / Q000188:drug therapy*; D013729:Terpenes / Q000627:therapeutic use*; D014527:Uric Acid
D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D013729:Terpenes; D014527:Uric Acid; D012964:Sodium; D010653:Phenylbutazone